← Leaderboards
Jeffrey A Ledbetter
Pacific Northwest Research Institute
$2,291,457
Attributed
$2,291,457
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $227.6K · FY2010–11$250K$187.5K$125K$62.5K$0
'10
'11
Funding mix
By agency
NIH$2,291,457 · 4
By mechanism
R01$1,282,500 · 1
R21$902,291 · 2
R43$106,666 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Receptor Expression”
- James C. Paulson · Scripps Research Institute$42,286,990
- Bert W O'Malley · Baylor College Of Medicine$37,971,442
- Barton F Haynes · Duke University$34,728,620
- Herbert Kim Lyerly · Duke University$34,617,942
- Carlos M Ferrario · Wake Forest University$34,549,500
- Fulton T Crews · University Of North Carolina Chapel Hill$33,872,927
Research focus
Receptor ExpressionHelper T LymphocyteCytotoxic T LymphocyteMonoclonal AntibodyCd AntigensNeoplastic CellAntireceptor AntibodyAntibody FormationNeoplasm /Cancer TherapyImmunoglobulin GenesGene ExpressionNeoplasm /Cancer GeneticsImmunologic Assay /TestAntitumor AntibodyT Cell ReceptorAnimal TissueFlow CytometryLeukocyte Activation /TransformationAntigen Antibody ReactionBiological Signal TransductionGene TherapyTissue /Cell CultureT LymphocyteTransfection /Expression Vector
Grant awards (9)
CD180(RP105) Regulation of TLR and BCR Responses in B Cells$193,050
R21 · FY2011 · AI · contact PI
CD180(RP105) Regulation of TLR and BCR Responses in B Cells$227,591
R21 · FY2010 · AI · contact PI
Cancer Therapy Using Small Modular Immunopharmaceuticals$106,666
R43 · FY2004 · CA
GENE THERAPY WITH MAB DRIVATIVES EXPRESSED ON TUMORS$315,000
R01 · FY2003 · CA
GENE THERAPY WITH MAB DRIVATIVES EXPRESSED ON TUMORS$315,000
R01 · FY2002 · CA
GENE THERAPY WITH MAB DRIVATIVES EXPRESSED ON TUMORS$315,000
R01 · FY2001 · CA
HIV-1 DNA VACCINES THAT TARGET AND ACTIVATE CD40$231,450
R21 · FY2001 · AI
GENE THERAPY WITH MAB DRIVATIVES EXPRESSED ON TUMORS$337,500
R01 · FY2000 · CA
HIV-1 DNA VACCINES THAT TARGET AND ACTIVATE CD40$250,200
R21 · FY2000 · AI